SCHEMBL5353834

SCHEMBL5353834

[O]C(=O)c1n[nH]c2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 5/20 0.65
▸ CDK2 P24941 2/20 0.65
▸ CCNA2 P20248 1/20 0.65
▸ CCNA1 P78396 1/20 0.65
▸ KDM4E B2RXH2 4/20 0.64
▸ YTHDC1 Q96MU7 1/20 0.64
▸ STAT3 P40763 1/20 0.64
▸ HIF1A Q16665 1/20 0.64
▸ CTNNB1 P35222 3/20 0.58
▸ WNT3A P56704 3/20 0.58
▸ IDO1 P14902 1/20 0.57
▸ NPC1 O15118 4/20 0.54
▸ RAB9A P51151 3/20 0.54
▸ EPHB3 P54753 1/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ CSNK2A1 P68400 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31148407 0.86 KDM4E (0.66) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL7668372 0.86 KDM4E (0.66) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL29444537 0.84 FLT3 (0.65) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL42245 0.84 FLT3 (0.65) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL591861 0.82 KDM4E (0.62) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL82761 0.82 KDM4E (0.62) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL967165 0.82 KDM4E (0.62) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL217086 0.82 KDM4E (0.67) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL30451174 0.82 KDM4E (0.62) FLT3CDK2CCNA2CCNA1KDM4E
SCHEMBL29781840 0.82 KDM4E (0.67) FLT3CDK2CCNA2CCNA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4371979-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT Kumiai Chemical Industry Co., Ltd. (JP) 2024-05-22 — — EP disclosed
WO-2023286855-A1 FORMAMIDE DERIVATIVE AND AGRICULTURAL OR HORTICULTURAL PLANT DISEASE CONTROL AGENT クミアイ化学工業株式会社 2023-01-19 — — WO disclosed
US-7217723-B2 Substituted benzothiophenes, e.g., 7Z)-7-hydroxyimino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-sulfonic acid [2-(4-fluorophenyl)-2-hydroxyethyl]-methyl-amide; treating allergies such as atopic dermatitis, allergic coryza, bronchial asthma, hypersensitive pneumoniac and pulmonary aspergillosis. EISAI CO., LTD. (JP) 2007-05-15 — — US disclosed
US-20050227959-A1 Heterocyclic compound having oxime group EISAI CO., LTD. (JP) 2005-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227959-A1 Heterocyclic compound having oxime group STAT6, HRH4, HRH2 FLT3 166/4885CDK2 402/4885CCNA2 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback